Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single-Center Phase I Open-Label Trial - Medco PRF

CALL NOW: (708) 237-3750

Course Registration

Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single-Center Phase I Open-Label Trial

Autism_Dawson_et_al-2017-STEM_CELLS_Translational_Medicine

By Medco PRF|2022-01-15T04:57:48-06:00October 26th, 2021|Articles|0 Comments

Leave A Comment Cancel reply